Simulations Plus
$73.169876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$73.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.39 (-1.86%) As of 3:32 PM UTC today
Why Robinhood?
You can buy or sell SLP and other stocks, options, and ETFs commission-free!
About SLP
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA. The listed name for SLP is Simulations Plus, Inc. Common Stock.
CEO
Shawn M. O'Connor
Employees
137
Headquarters
Lancaster, California
Founded
1996
Market Cap
1.45B
Price-Earnings Ratio
142.05
Dividend Yield
0.33
Average Volume
302.78K
High Today
$75.09
Low Today
$73.12
Open Price
$74.75
Volume
35.23K
52 Week High
$83.78
52 Week Low
$26.00
Collections
SLP Earnings
$0.00
$0.07
$0.13
$0.20
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$0.11 per share
Actual
$0.12 per share